Join Us: The New Alzheimer’s Prevention National Goal - Why It Matters & What Is Next

The Brain Health Partnership meeting will discuss the recent and tremendous victory realized by the Alzheimer's community -- making the prevention of Alzheimer's and related dementia a national priority.

Myth vs. Fact: CMS Draft Decision on Alzheimer’s Drugs

With so much misinformation surrounding the draft National Coverage Determination (NCD) from CMS not to cover the first class of Alzheimer’s drugs, except in very limited circumstances, UsAgainstAlzheimer’s is setting the record straight.

Medicare Slams the Door on Alzheimer’s Treatments

The Centers for Medicare and Medicaid Services announced it only plans to cover anti-amyloid treatments (such as Aduhelm) under a Coverage with Evidence Development (CED), effectively denying access to an entire class of drugs for years to come and further exacerbating health disparities.

New Data Shows Global Dementia Cases Expected To Reach 150 Million By 2050

A new report from The Lancet projects that the number of adults living with dementia globally will triple to over 150 million by 2050 and spotlights the importance of potentially mofiable risk factors for dementia.

Federal Government Makes Risk Reduction for Alzheimer’s a National Priority

The United States has made the prevention of Alzheimer’s and related dementias a national priority in the fight to end the disease, adding a new risk reduction goal to the National Alzheimer’s Plan.

Say Hello to BrainGuide

Our platform BrainGuide™ empowers people of all ages and communities to understand and take action on brain health and Alzheimer's disease.

The New Alzheimer’s Prevention National Goal - Why It Matters & What Is Next

Myth vs. Fact: CMS Draft Decision on Alzheimer’s Drugs

Medicare Slams the Door on Alzheimer’s Treatments

Global Dementia Cases Expected To Reach 150 Million By 2050

Federal Government Makes Risk Reduction for Alzheimer’s a National Priority

Say Hello to BrainGuide

UsAgainstAlzheimer's: Working to End Alzheimer's Disease  

The Alzheimer’s pandemic is one of the most significant health and social economic crises of this generation. It is a national and global emergency that has a devastating health, social and economic toll on millions of people living with this disease, their families and caregivers.

UsAgainstAlzheimer’s exists to conquer Alzheimer’s disease. Since our founding in 2010, we have taken on the toughest problems in the fight to end Alzheimer’s. Our work is driven by the urgency to find effective treatments and the prevention steps needed to reach the time where no one is lost to Alzheimer’s.

We bring all of “Us” together to:

In the past decade, progress has been made, with more hope on the horizon now than ever before.

But every day of delay is another day lost to the millions of people affected by this devastating disease. If nothing changes, by 2050, 14 million Americans will be living with Alzheimer’s at an annual cost of more than $1 trillion. The time to act is now.

Recent News and Blog Posts

  • January 19, 2022

    Myth vs. Fact: CMS Draft Decision on Alzheimer’s Drugs

    With so much misinformation surrounding the draft National Coverage Determination (NCD) from...

    Read more
  • January 13, 2022

    New Guidance Provides Clinical Recommendations to Reduce Dementia Risk

    Today, Primary Prevention Recommendations to Reduce the Risk of Cognitive Decline...

    Read more
  • January 12, 2022

    Medicare Slams the Door on Alzheimer’s Treatments

    The Centers for Medicare and Medicaid Services (CMS) announced today that it...

    Read more
  • January 10, 2022

    UsAgainstAlzheimer’s Applauds HHS Secretary Becerra for Calling on Medicare to Reexamine its Planned Premium Increase

    Just weeks after UsAgainstAlzheimer’s urged Health and Human Services Secretary Xavier Becerra...

    Read more
  • January 07, 2022

    UsAgainstAlzheimer’s Calls on Medicare to Cover Aduhelm for Alzheimer’s Patients

    study released today shows that the number of adults living with...

    Read more
  • December 27, 2021

    UsAgainstAlzheimer’s Celebrates Federal Government Action Making Risk Reduction for Alzheimer’s and Related Dementias a National Priority

    The United States today made the prevention of Alzheimer’s and related dementias...

    Read more

Reports

  • Resources

    A-LIST Pulse of the Community - December 2021

  • Resources

    2020 Annual Report

    In these pages, you will find highlights of the game-changing accomplishments and tremendous progress of UsAgainstAlzheimer's and our partners in the year of 2020. 

  • Resources
    Thumbnail

    Place & Brain Health Equity: Understanding the County-Level Impacts of Alzheimer’s

    The effects of where people live, and the social determinants of health are under-recognized and under-appreciated in our national response to effectively treat and prevent Alzheimer’s. This report found that...